porcin
hemagglutin
encephalomyel
viru
phev
nonseg
positivesens
singlestrand
rna
coronaviru
belong
genu
betacoronaviru
togeth
mous
hepat
viru
mhv
human
coronaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
other
http
wwwncbinlmnihgovtaxonomybrowserwwwtaxcgi
phev
initi
isol
encephalomyelit
suckl
piglet
brain
sinc
sever
outbreak
phev
infect
report
affect
piglet
exhibit
vomit
wast
diseas
vwd
andor
encephalomyel
overal
mortal
rate
affect
piglet
week
age
rang
phev
propag
via
neural
circuit
central
nervou
system
cn
target
nerv
cell
site
replic
result
sever
nerv
damag
although
major
progress
made
past
decad
toward
understand
viral
characterist
mani
patholog
aspect
viru
yet
character
coronavirus
cov
health
threat
wide
varieti
mammalian
avian
speci
coronaviru
spike
glycoprotein
contain
two
distinct
domain
function
receptorbind
domain
rbd
recogn
protein
sugar
receptor
therefor
protein
major
determin
viral
host
rang
involv
viral
bind
fusion
set
process
result
coronaviru
entri
coronavir
rbd
locat
phev
protein
found
interact
neural
cell
adhes
molecul
ncam
particip
viral
infect
suggest
phev
entri
occur
via
receptor
recognit
pattern
subsequ
electron
microscop
analysi
demonstr
membran
coatingmedi
endo
exocytosi
employ
phev
transsynapt
transfer
evid
regard
mechan
phev
entri
limit
detail
comprehens
studi
endocyt
mechan
involv
phev
uptak
urgent
need
viral
entri
initi
step
toward
success
infect
envelop
virus
achiev
intern
via
two
primari
pathway
virus
appear
fuse
directli
plasma
membran
wherea
other
take
advantag
endocyt
mechan
host
anim
virus
gain
access
target
cell
hijack
host
endocyt
pathway
clathrinmedi
endocytosi
cme
macropinocytosi
caveolaraftmedi
endocytosi
clathrin
caveolinraftindepend
endocytosi
variat
theme
yet
well
character
cme
evolutionarili
conserv
endocyt
pathway
character
uptak
cargo
transferriniron
complex
toxin
virus
invagin
clathrinco
vesicl
ccv
primari
rout
intern
mani
virus
includ
african
swine
fever
viru
asfv
vesicular
stomat
viru
vsv
rabi
viru
rabv
process
low
ph
play
essenti
role
dynam
endosom
system
tightli
regul
small
ra
relat
brain
rab
gtpase
anoth
wellcharacter
pathway
caveolaraftdepend
endocytosi
caveola
defin
special
lipid
raft
domain
compos
caveolin
high
level
cholesterol
pathway
requir
uniqu
structur
signal
machineri
involv
intern
envelop
virus
human
immunodefici
viru
hiv
human
coronaviru
infecti
spleen
kidney
necrosi
viru
isknv
among
other
addit
research
recent
decad
found
virus
induc
macropinocytosi
direct
endocyt
rout
product
entri
infect
far
phev
enter
host
cell
start
product
infect
yet
explor
present
work
address
role
differ
endocyt
molecul
pathway
involv
phev
entri
intracellular
traffick
host
cell
thu
combin
pharmacolog
molecular
techniqu
carri
allow
visual
track
local
phev
result
indic
cme
part
phev
infect
process
host
cell
membran
cholesterol
low
ph
dynam
actin
cytoskeleton
specif
requir
addit
activ
significantli
affect
earli
stage
phev
infect
disturb
viru
transport
endocytos
vesicl
postentri
stage
togeth
data
contribut
greatli
patholog
character
phev
entri
intracellular
traffick
rout
also
provid
new
insight
antivir
drug
design
kinet
phev
infect
assess
immunofluoresc
assay
ifa
use
antiphev
antibodi
cell
infect
assay
show
percentag
phev
entri
cell
initi
increas
rapidli
reach
halfmaxim
level
min
infect
plateau
h
fig
base
data
time
requir
phev
entri
estim
approxim
min
condit
assay
valu
use
interpret
phev
intern
assay
report
paper
detect
cours
phev
entri
visual
cell
inocul
purifi
phev
virion
min
ice
employ
thinsect
transmiss
electron
microscopi
tem
observ
attach
viru
particl
along
cell
surfac
cell
shift
allow
entri
subsequ
phev
engulf
coat
pit
may
repres
primari
endocyt
vesicl
fig
panel
endocytos
virion
mainli
trap
within
larg
vesicl
cytoplasm
either
individu
group
fig
panel
b
viruscontain
coat
vesicl
transport
intracellularli
viru
fuse
endosom
membran
nucleocapsid
releas
fig
panel
c
subsequ
viral
replic
protein
structur
synthesi
wide
observ
min
postinfect
fig
panel
earlier
sign
viral
assembl
observ
insid
cytoplasm
larg
number
virion
undecor
membran
present
dilat
cisterna
golgi
network
fig
panel
e
infect
progress
small
coat
vesicl
tightli
enclos
singl
envelop
virion
appar
fuse
plasma
membran
progeni
virion
seem
releas
cell
open
fusion
site
membran
coat
remain
releas
site
fig
panel
f
find
rais
evid
membran
coatingmedi
endo
exocytosi
use
phev
invas
cellular
transfer
previous
report
ncam
potenti
cellular
receptor
interact
phev
protein
associ
critic
phev
infect
cell
incub
phev
fix
indic
time
ifa
use
antincam
antiphev
antibodi
dual
stain
assay
ncam
phev
show
ncam
local
primarili
cell
surfac
normal
condit
express
induc
protein
transport
plasma
membran
intracellular
compart
incub
phev
h
wherea
coloc
two
protein
vesicl
observ
perinuclear
area
fig
addit
h
incub
ncamcontain
vesicl
less
visibl
within
cytoplasm
instead
seen
cluster
near
cell
surfac
suggest
receptor
recycl
like
endocytosi
fig
earli
endosom
autoantigen
membran
tether
factor
requir
fusion
matur
ee
endocytosi
confirm
phev
enter
cell
via
endocyt
pathway
dual
immunostain
phev
earli
endosom
ee
marker
protein
perform
observ
punctat
pattern
character
indic
coloc
suggest
phev
intern
ee
fig
posit
control
monitor
traffick
alexalabel
transferrin
tf
bind
receptor
intern
coat
vesicl
follow
fusion
endosom
intern
within
primari
endocyt
vesicl
mani
virus
requir
acid
ph
endosom
undergo
uncoat
andor
escap
endosom
local
ph
drop
follow
intern
endolysosom
test
whether
phev
entri
ph
depend
cell
pretreat
weakli
basic
amin
chloroquin
cq
select
rais
lumin
ph
endosom
lysosom
cell
infect
phev
presenc
either
mm
cq
phev
intern
decreas
less
level
found
untreat
cell
reagent
inhibit
viral
protein
synthesi
even
low
concentr
fig
moreov
rel
infect
rate
phev
monitor
ifa
inhibit
dosedepend
manner
fig
result
reflect
normal
traffic
membran
flow
indic
intern
phev
endocyt
vesicl
fuse
ee
process
occur
lowphdepend
manner
gtpase
respons
endocytosi
play
essenti
role
cellular
membran
fission
vesicl
format
therefor
requir
clathrin
caveolamedi
endocytosi
use
dynasor
cellperm
noncompetit
inhibitor
dynamin
ascertain
whether
phev
infect
dynamin
depend
cell
pretreat
dynasor
h
phev
infect
lysat
harvest
quantit
revers
transcriptionpcr
qrtpcr
assay
control
monitor
impact
inhibitor
infect
vsv
whose
intern
previous
prove
occur
clathrin
dynamindepend
manner
treatment
cell
dynasor
result
decreas
phev
intern
fig
suppress
last
h
postinfect
fig
impli
might
play
crucial
role
multipl
stage
viral
life
cycl
test
special
function
dynasor
treatment
cell
chemic
inhibitor
block
uptak
fluoresc
label
transferrin
cargo
intern
via
dynamin
clathrindepend
endocyt
mechan
fig
situat
also
observ
signific
inhibit
viral
load
cytoplasm
dynasoretr
cell
rel
control
cell
fig
next
explor
effect
domin
neg
dn
mutant
previous
describ
decreas
gtpase
activ
result
reduc
endocytosi
cell
overexpress
infect
h
later
phev
show
decreas
nearli
phev
infect
fig
howev
control
cell
express
either
enhanc
green
fluoresc
protein
egfp
wildtyp
normal
infect
observ
indic
punctat
stain
cytoplasm
region
find
indic
phev
endocytosi
depend
function
better
understand
pathway
use
phev
enter
cell
compar
sensit
inhibitor
differ
endocyt
mechan
chlorpromazin
cpz
specif
inhibitor
commonli
use
block
cme
pathway
prevent
assembl
clathrinco
pit
ccp
plasma
membran
caus
clathrin
lattic
assembl
endosom
membran
cell
treat
cpz
incub
phev
plu
ice
min
shift
min
fix
uptak
assay
cell
pretreat
cpz
exhibit
signific
decreas
tf
uptak
occur
cme
suppress
exhibit
reduct
phev
infect
fig
period
observ
phev
mostli
appear
coloc
transport
togeth
tf
larg
endosom
structur
intern
assay
found
entri
effici
phev
significantli
decreas
highest
work
concentr
cpz
fig
furthermor
drug
stimul
significantli
suppress
viral
genom
replic
protein
translat
level
determin
qrtpcr
immunoblot
fig
role
cme
test
express
gfptag
domin
neg
mutant
crucial
compon
ccp
interact
adaptor
protein
major
clathrin
adaptor
complex
cell
overexpress
infect
phev
signific
blockag
infect
compar
cell
express
wildtyp
egfp
control
fig
clathrin
protein
perform
critic
role
format
coat
vesicl
cytoplasm
intracellular
traffick
form
triskelion
shape
compos
clathrin
heavi
chain
chc
light
chain
clc
former
known
key
compon
regul
format
disassembl
clathrin
lattic
observ
phev
mostli
coexpress
clathrin
h
postinfect
hpi
could
indic
presenc
ccp
cme
fig
sinc
preliminari
result
show
cme
involv
phev
entri
cell
perturb
assay
use
small
interf
rna
sirna
mediat
knockdown
chc
sichc
carri
evalu
necess
clathrin
viral
infect
twentyfour
hour
transfect
phev
entri
assay
perform
transfect
cell
found
sichc
specif
decreas
express
chc
wherea
viral
intern
prolifer
reduc
dosedepend
manner
fig
meanwhil
stain
assay
show
fluoresc
signal
chc
phev
nm
sichctransfect
cell
reduc
approxim
respect
compar
control
sirna
sictrl
transfect
group
fig
taken
togeth
coincid
result
strongli
suggest
phev
entri
cell
occur
effici
via
cme
endocyt
process
sensit
cholesterol
perturb
cme
caveolalipid
raft
endocytosi
inhibit
remov
cholesterol
cholera
toxin
subunit
b
ctb
bind
gangliosid
lipid
raft
travel
via
caveosom
deliveri
golgi
apparatu
consequ
use
tracer
marker
caveolalipid
raft
endocytosi
cell
treat
dimethyl
sulfoxid
dmso
control
nystatinprogesteron
nysprog
genistein
min
phev
plu
ctb
incub
ice
phev
allow
intern
min
subject
microscop
assay
distinct
endocyt
compart
structur
label
phev
green
ctb
red
studi
show
sort
two
ligand
deliveri
distinct
endosom
popul
suggest
phev
ctb
take
differ
intracellular
target
rout
golgi
apparatu
endoplasm
reticulum
er
perinuclear
region
fig
upper
panel
caveolalipid
raft
endocytosi
known
sensit
nonacut
cholesterol
deplet
induc
pharmacolog
agent
nysprog
thu
select
extract
membran
cholesterol
plasma
membran
treat
cell
phev
ad
found
mm
treatment
result
notic
shift
ctb
punctat
cytoplasm
distribut
locat
predominantli
plasma
membran
quantit
analys
reveal
signific
reduct
amount
intern
ctb
indic
cholesteroldepend
pathway
effect
block
fig
b
deplet
assay
observ
intern
fig
immunofluoresc
fig
b
assay
phev
entri
suppress
approxim
though
abolish
major
phev
ctb
settl
outsid
surfac
plasma
membran
cholesteroldeplet
cell
infect
phev
found
perturb
cholesterol
fluiditi
inhibit
viral
genom
replic
also
affect
viral
protein
synthesi
fig
similar
observ
assay
uptak
ctb
block
pretreat
nysprog
stay
outsid
plasma
membran
without
intern
phev
entri
replic
prolifer
notabl
inhibit
fig
data
confirm
phev
enter
via
cholesterolsensit
endocyt
rout
caveolalipid
raft
endocytosi
occur
via
signal
bind
viral
cargo
cell
surfac
activ
tyrosin
kinasebas
signal
cascad
result
slow
effici
intern
thu
use
wellknown
tyrosin
kinas
inhibitor
genistein
disrupt
complex
pathway
check
uptak
phev
ctb
observ
cell
pretreat
genistein
show
signific
reduct
ctb
intern
slight
facilit
phev
infect
fig
observ
impli
signal
cascad
caveolalipid
raftdepend
pathway
neg
regul
phev
aggreg
phev
entri
probabl
occur
via
caveolalipid
raftindepend
rout
verifi
specul
examin
role
caveola
viral
infect
given
essenti
format
stabil
caveola
repres
scaffold
molecul
sever
signal
molecul
small
interf
rna
target
use
studi
character
caveolar
invagin
effici
knockdown
first
valid
western
blot
fig
follow
phev
entri
assay
expect
reduct
express
rna
interfer
rnai
significantli
affect
viral
intern
infect
transfect
cell
suggest
phev
hijack
caveolalipid
raftmedi
rout
gain
entri
cell
fig
f
taken
togeth
result
reveal
phev
entri
depend
fluiditi
cholesterol
involv
caveolalipid
raftdepend
endocytosi
apart
clathrin
caveolaraftdepend
endocyt
process
macropinocytosi
uniqu
mode
endocytosi
receiv
increas
attent
role
immun
defens
viru
entri
recent
studi
indic
actin
cytoskeleton
involv
regul
multipl
endocyt
pathway
particular
factin
polymer
critic
format
outward
protrus
plasma
membran
macropinocytosi
test
whether
phev
interact
protrus
undergo
rapid
actindriven
transport
entri
site
cell
bodi
cell
incub
phev
label
lipophil
fluoresc
dye
didphev
fix
variou
time
point
actin
examin
use
phalloidin
stain
repres
micrograph
shown
fig
without
phev
infect
min
cell
produc
random
filopodi
protrus
show
smooth
margin
cell
surfac
peripher
actin
stain
first
min
postinfect
found
didphev
associ
protrus
base
filopodia
cell
surfac
densiti
decreas
later
time
point
approxim
min
postinfect
membraneannulu
phase
began
bound
virus
surf
toward
foot
filopodia
locat
cell
bodi
actin
retrograd
flow
time
actin
cytoskeleton
depolymer
occur
number
actin
stress
fiber
decreas
cell
becom
round
transient
bleb
fill
actin
form
cell
surfac
within
min
annulu
disappear
actin
accumul
bleb
flaki
pseudopod
didphev
transport
perinuclear
cisterna
data
show
increas
distribut
actin
cytoskeleton
flow
cell
phev
uptak
impli
viral
entri
like
actin
molecular
motordriven
process
examin
involv
actin
phev
entri
use
cytochalasin
cytod
revers
induc
depolymer
exist
filament
increas
cellular
pool
adpbound
actin
monom
cell
pretreat
cytod
nethylnisopropyl
amilorid
eipa
indic
concentr
h
phev
intern
examin
qrtpcr
observ
phev
intern
block
actin
polymer
inhibit
cell
fig
confoc
microscopi
assay
highlight
pretreat
cytod
strongli
disrupt
actin
polym
inhibit
phev
infect
cell
block
uptak
solubl
fluoresc
tracer
actindepend
pathway
fig
control
group
cell
pretreat
dmso
process
later
studi
meanwhil
phev
rna
replic
protein
synthesi
also
reduc
drug
earli
stage
ie
hpi
fig
e
suggest
function
actin
cytoskeleton
reorgan
requir
process
therefor
examin
stage
intern
affect
actin
depolymer
shown
schemat
fig
cytod
ad
either
min
prior
inocul
viru
hpi
maintain
analysi
phev
intern
assay
qrtpcr
hpi
inhibit
actin
polymer
prior
addit
viru
result
reduct
phev
infect
treatment
cell
cytod
h
postinocul
neglig
effect
phev
accumul
detect
confirm
requir
actin
specif
earli
stage
viru
intern
h
postinocul
fig
minim
set
requir
satisfi
definit
viru
macropinocytosi
outlin
includ
actin
dynam
nah
exchang
nhe
activ
other
particip
nhe
critic
format
macropinocyt
protrus
use
inhibitor
eipa
specif
inhibit
exchang
intracellular
h
extern
na
clarifi
role
macropinocytosi
phev
entri
treatment
eipa
significantli
reduc
uptak
cytoplasm
show
margin
effect
intern
differ
phev
entri
infect
observ
eipatr
cell
qrtpcr
western
blot
ifa
fig
e
g
data
provid
strong
evid
suggest
entri
phev
cell
reli
critic
actin
reorgan
independ
macropinocytosi
rab
famili
small
gtpase
known
play
crucial
role
orchestr
membran
traffic
local
cargo
specif
subcellular
compart
gener
detach
plasma
membran
envelop
rna
viru
particl
traffick
ee
mark
either
sort
recycl
endosom
re
mark
direct
late
endosom
le
endolysosom
ly
posit
respect
therefor
first
analyz
express
correspond
marker
molecul
western
blot
use
specif
antibodi
found
express
significantli
enhanc
presenc
phev
express
significantli
affect
fig
determin
whether
phev
particl
tightli
associ
endosom
traffick
label
ee
le
transfect
construct
function
confirm
cell
label
transferrin
serv
control
fig
next
employ
transfect
cell
studi
phev
entri
found
viru
particl
coloc
infect
indic
involv
phev
infect
fig
confirm
observ
transfect
cell
gtpbindingdefect
dn
mutant
found
uptak
tracer
larg
reduc
mutant
overexpress
fig
transfect
obvious
block
traffick
phev
cargo
cytoplasm
leav
beneath
cytoplasm
membran
infect
cell
moder
decreas
observ
cell
indic
requir
fig
abovement
overexpress
studi
averag
fluoresc
signal
phev
quantifi
result
valu
summar
histogram
fig
identifi
endosom
compart
travers
endocytos
phev
knock
rnai
mean
investig
necess
ee
le
viral
entri
cell
pretransfect
nm
sictrl
nm
nm
h
follow
phev
infect
cell
lysat
harvest
hpi
western
blot
confirm
level
cell
effici
knock
sirna
synthesi
phev
protein
inhibit
compar
sictrltransfect
cell
fig
result
confirm
qrtpcr
ifa
observ
signific
reduct
viral
entri
infect
sirabtransfect
cell
fig
b
suggest
involv
transport
phev
intern
product
infect
investig
endocyt
trail
follow
phev
allow
fluoresc
label
didphev
particl
bind
cell
pretransfect
rab
construct
shown
fig
viral
signal
captur
cytoplasm
didphevcontain
organel
acquir
fuse
ee
approxim
min
postintern
seventyf
minut
later
cotransport
phev
gradual
disappear
didphev
particl
detect
le
min
postintern
coloc
phev
wide
appar
given
cotransport
didphev
particl
cytoplasm
conclud
ee
le
requir
viral
transport
undergo
endosom
matur
initi
infecti
cycl
rab
famili
gtpase
whose
activ
depend
gdpgtp
associ
play
central
role
intracellular
transport
gener
term
gtp
bind
rab
allow
recruit
effector
mediat
vesicular
movement
cytoskeleton
fusion
membran
process
revers
bidirect
earlier
work
show
deplet
larger
effect
deplet
phev
entri
transport
see
suggest
function
may
play
import
role
phev
infect
thu
directli
examin
possibl
phev
may
facilit
activ
intern
intracellular
traffick
given
gtpase
activ
cell
monitor
level
activ
gtpbound
determin
use
glutathion
stransferas
gst
pulldown
assay
specif
bind
ctermin
domain
effector
fusion
protein
gener
pull
studi
prior
step
interact
determin
coimmunoprecipit
fig
posit
neg
control
constitut
activ
mutant
gtpbindingdefect
mutant
respect
transfect
cell
follow
gtpase
activ
detect
use
pulldown
assay
overexpress
produc
robust
pulldown
signal
reflect
high
gtpase
activ
signal
complet
inhibit
transfect
dn
isoform
demonstr
feasibl
pulldown
assay
determin
rel
amount
cell
fig
base
proceed
perform
activ
assay
determin
rel
amount
underli
phev
infect
endogen
level
low
detect
therefor
nonhydrolyz
gtp
analog
guanosin
gamma
thiophosph
ad
activ
small
g
protein
posit
control
found
phev
rapidli
upregul
activ
endogen
h
postinfect
fig
indic
play
role
process
determin
whether
phev
invas
may
affect
level
overexpress
wildtyp
domin
activ
da
domin
neg
dn
construct
cell
follow
phev
infect
hpi
cell
lyse
harvest
immunoblot
analysi
indic
antibodi
expect
overexpress
highgtpaseact
isoform
facilit
phev
rna
replic
prolifer
overexpress
dn
isoform
significantli
inhibit
product
infect
fig
group
cell
show
increas
pulldown
signal
much
lesser
extent
fig
wherea
phev
infect
higher
egfptransfect
group
fig
profil
similar
find
observ
ifa
overexpress
increas
phev
infect
also
form
sortingdefect
enlarg
vesicl
allow
us
easili
detect
virion
particl
reinforc
notion
viru
traffic
ee
fig
result
evidenc
increas
endocytosi
overexpress
induc
format
enlarg
vesicl
recruit
excess
accumul
compar
cell
express
fig
contrast
express
reduc
uptak
control
level
fig
togeth
result
suggest
gtpase
critic
phev
propag
endogen
function
may
need
activ
viral
entri
intracellular
traffick
porcin
hemagglutin
encephalomyel
acut
highli
contagi
diseas
caus
phev
lead
vomit
depress
pallor
dehydr
well
neurolog
sign
abnorm
gait
dull
anorexia
tremor
nystagmu
sinc
diseas
first
broke
phev
infect
report
success
sever
pigrais
countri
includ
unit
state
japan
argentina
belgium
south
korea
china
though
epidemiolog
pathogenesi
phev
gradual
character
littl
inform
avail
infecti
cell
entri
pathway
studi
first
investig
cell
entri
process
phev
particl
moreov
reveal
involv
phev
invas
intracellular
traffick
cell
understand
viral
entri
pathway
earli
critic
step
infect
host
cell
import
understand
viral
pathogenesi
design
antivir
drug
coronaviru
entri
larg
control
glycoprotein
sinc
bear
receptor
bind
membran
fusion
capabl
initi
receptor
bind
larg
conform
chang
protein
evolv
depend
coronaviru
speci
strain
protein
mediat
bind
proteinac
receptor
carbohydr
moieti
therebi
multitud
mechan
strategi
viru
entri
exploit
exampl
mhv
strain
capabl
enter
directli
cell
surfac
endocyt
pathway
sarscov
initi
thought
enter
cell
direct
fusion
plasma
membran
recent
evid
suggest
viru
entri
may
also
occur
novel
clathrin
caveolaindepend
endocyt
pathway
increas
evid
demonstr
choic
coronaviru
entri
mechan
complex
studi
phev
entri
mechan
notabl
increasingli
central
understand
infect
process
endocyt
pathway
taken
virus
commonli
use
cme
rout
clathrin
first
recruit
assembl
ccp
cytoplasm
side
membran
respons
receptormedi
endocytosi
signal
compos
light
chain
clc
heavi
chain
chc
studi
rna
interfer
assay
indic
clathrin
requir
phevinduc
format
ccp
bind
site
assembl
finish
ccp
pinch
plasma
membran
form
clathrinco
vesicl
ccv
involv
dynam
function
around
neck
endocyt
indent
larg
gtpase
requir
variou
type
endocytosi
intracellular
scission
event
indispens
cme
found
phev
endocytosi
lowphdepend
natur
prompt
us
hypothes
phev
entri
quick
process
accord
characterist
cme
expect
disrupt
assembl
clathrin
lattic
block
recruit
ccp
decreas
phev
entri
show
occur
via
cme
cholesterol
essenti
structur
invagin
caveola
ccp
within
cell
membran
therebi
function
caveola
clathrindepend
endocytosi
caveolalipid
raftmedi
endocytosi
character
caveola
smooth
cholesterol
sphingolipidrich
invagin
plasma
membran
gener
associ
caveolin
data
show
cholesterol
deplet
suppress
phev
infect
impli
fluiditi
cholesterol
import
phev
entri
replic
though
pivot
factor
interestingli
tyrosin
kinas
inhibitor
use
disrupt
caveola
function
affect
phev
infect
togeth
fact
knockdown
bare
obstacl
phev
prolifer
find
suggest
phev
entri
occur
disabl
caveolamedi
endocytosi
per
se
like
alter
integr
membran
lipid
microdomain
bind
mani
virus
move
later
along
cell
surfac
intern
follow
bind
filopodia
surf
toward
cell
bodi
actin
retrograd
flow
phev
observ
viru
particl
locat
actinrich
protrus
move
toward
coloc
dotlik
actin
long
actin
filament
subsequ
phev
induc
rearrang
actin
cytoskeleton
point
greater
role
actin
cytoskeleton
viral
entri
transport
date
actin
cytoskeleton
involv
phev
intern
clearli
demonstr
data
show
specif
contribut
still
miss
intern
within
primari
endocyt
vesicl
mani
virus
deliv
suitabl
endosom
intracellular
organel
follow
intracellular
pathway
endosomallysosom
system
respons
molecular
sort
recycl
degrad
storag
process
owe
restrict
express
pattern
specif
endocyt
compart
abil
recruit
distinct
effector
rab
gtpase
power
tool
discrimin
pathway
lead
differ
intracellular
locat
present
studi
monitor
intracellular
traffick
follow
endocytosi
show
phev
infect
regul
ee
le
endolysosom
involv
recycl
endosom
process
uncertain
fig
rab
activ
play
role
endocytosi
gener
rab
cycl
gtpbound
gdpbound
state
convers
two
state
regul
gtpaseactiv
protein
gdp
exchang
factor
gdp
dissoci
inhibitor
gdi
rab
escort
protein
effector
molecul
overexpress
constitut
activ
mutant
gtpasedefici
mutant
clearli
demonstr
activ
function
earli
endocyt
pathway
requir
effect
phev
infect
howev
whether
phev
infect
depend
lysosom
activ
remain
unexplor
summari
conduct
first
systemat
studi
dissect
intern
intracellular
traffick
mechan
phev
cell
find
highli
relev
develop
futur
therapi
direct
phev
date
specif
antivir
drug
shown
effect
treat
phev
infect
better
understand
molecular
pathogenesi
involv
porcin
hemagglutin
encephalomyel
like
open
new
approach
develop
novel
therapeut
strategi
howev
mani
aspect
phev
infect
underli
physiolog
process
remain
character
move
forward
import
take
advantag
power
novel
technolog
combin
improv
assay
follow
viru
step
step
replic
cycl
achiev
unpreced
access
underli
network
cellular
factor
involv
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
hyclon
penicillinstreptomycin
phev
strain
use
experi
hev
genbank
access
number
success
propag
cell
atcc
cell
line
sensit
infect
phev
use
extens
viru
infect
replic
studi
phev
entri
replic
determin
viral
infect
perform
inocul
phev
multipl
infect
moi
cell
cultur
indic
time
rna
isol
cell
lysi
endocyt
inhibitor
ie
chlorpromazin
cpz
genistein
nystatin
ny
progesteron
prog
ammonium
chlorid
chloroquin
cq
cytochalasin
cytod
nethylnisopropyl
amilorid
eipa
dynasor
purchas
sigma
antibodi
ncam
purchas
cell
signal
technolog
antibodi
purchas
abcam
alexa
fluor
transferrin
alexa
fluor
cholera
toxin
subunit
b
alexa
fluor
dextran
obtain
invitrogen
phalloidin
purchas
cytoskeleton
inc
denver
co
studi
mous
antiphev
antibodi
monoclon
antibodi
weigh
kda
recogn
protein
phev
use
western
blot
immunofluoresc
analys
total
rna
extract
use
trizol
reagent
invitrogen
revers
transcript
perform
use
primescript
revers
transcriptas
takara
japan
qrtpcr
conduct
fs
univers
sybr
green
master
mix
roch
touch
realtim
pcr
detect
system
biorad
usa
dehydrogenas
gapdh
control
purpos
normal
western
blot
cell
wash
three
time
phosphatebuff
salin
pb
lyse
ripa
lysi
buffer
triton
mm
phenylmethylsulfonyl
fluorid
pmsf
pb
ice
separ
sdspage
protein
lysat
electrotransf
polyvinyliden
difluorid
pvdf
membran
immunoblot
indic
antibodi
gapdh
use
load
control
test
intern
prechil
cell
min
expos
phev
ice
min
viru
bind
icecold
pb
ph
ad
complet
remov
unbound
virus
cell
shift
allow
intern
cell
incub
indic
time
span
treat
citrat
buffer
mm
sodium
citrat
mm
kcl
mm
nacl
ph
inactiv
remov
nonintern
virus
cell
either
fix
visual
microscopi
antiphev
antibodi
subject
qrtpcr
analysi
experi
involv
inhibitor
stimul
cell
pretreat
indic
inhibitor
h
addit
phev
ice
remain
step
conduct
describ
cell
plate
plate
densiti
cellswel
grown
h
precool
icewat
bath
min
phev
ad
incub
addit
min
ice
cultur
shift
zero
min
temperatur
shift
cell
collect
fix
glutaraldehyd
min
postfix
osmium
tetroxid
h
stepwis
dehydr
ethanol
specimen
embed
epon
resin
polymer
h
ultrathin
section
stain
brass
wire
mesh
uranyl
acet
min
lead
citrat
min
visual
transmiss
electron
microscop
cell
seed
plate
densiti
cellswel
grown
h
treat
endocytosi
inhibitor
indic
concentr
h
two
wash
dmem
solut
ad
dmem
well
plate
incub
h
absorb
nm
measur
micropl
reader
experi
carri
triplic
error
bar
figur
repres
standard
deviat
sd
concentr
chemic
reagent
use
studi
caus
signific
cytotox
effect
cell
viabil
tabl
confluent
monolay
cell
grown
plate
wash
twice
pb
pretreat
appropri
concentr
drug
min
cultur
infect
phev
h
presenc
correspond
inhibitor
wash
twice
pb
incub
addit
h
indic
time
cell
process
ifa
qrtpcr
western
blot
plasmid
wildtyp
wt
sequenc
domin
activ
da
domin
neg
dn
mutant
sequenc
construct
use
convent
clone
techniqu
determin
infect
phev
cell
pretransfect
plasmid
cell
use
xtremegen
hp
dna
transfect
reagent
roch
sweden
accord
manufactur
instruct
rna
interfer
assay
sirna
clathrin
heavi
chain
sichc
design
base
fulllength
mrna
sequenc
access
number
sirna
control
sequenc
irrelev
known
gene
sictrl
also
design
synthes
cell
transfect
appropri
sirna
use
xtremegen
sirna
transfect
reagent
accord
manufactur
instruct
knockdown
effici
quantifi
western
blot
subsequ
experi
perform
h
transfect
cell
grow
glass
coverslip
fix
paraformaldehyd
min
permeabil
triton
min
block
bovin
serum
albumin
bsa
h
room
temperatur
cell
probe
primari
antibodi
ie
antincam
antiphev
h
three
wash
pb
cell
incub
h
room
temperatur
secondari
antibodi
antimous
igg
antibodi
conjug
alexa
fluor
alexa
fluor
antirabbit
igg
antibodi
conjug
alexa
fluor
molecular
probe
dilut
cell
nuclei
label
dapi
sigma
da
dn
protein
assay
cell
pretransfect
egfp
plasmid
encod
infect
phev
immunolabel
describ
actin
rearrang
analysi
monolay
incub
fluorescein
isothiocyan
fitc
phalloidin
h
immunolabel
describ
percentag
cell
normal
disorgan
actin
filament
determin
specif
label
absenc
signal
crossov
confirm
examin
singlelabel
control
sampl
imag
acquir
randomli
differ
field
view
coverslip
cell
per
field
use
laser
scan
confoc
fluoresc
microscop
olympu
fluoview
viru
infect
motil
subcellular
coloc
analyz
use
imagej
matlab
phev
purifi
sucros
densiti
gradient
centrifug
viru
first
purifi
sucros
cushion
ultracentrifug
hitachi
g
h
viru
exchang
pb
cycl
concentr
centrifug
g
h
dilut
pb
purifi
phev
freshli
label
lipophil
fluoresc
dye
salt
life
technolog
dialkylcarbocyanin
analog
markedli
redshift
fluoresc
excit
emiss
spectra
wide
use
label
tracer
live
fix
cell
briefli
phev
stock
solut
mix
min
free
dye
remov
use
gel
filtrat
column
ge
healthcar
hs
buffer
mm
hepe
mm
nacl
cell
infect
didphev
imag
obtain
analyz
use
confoc
microscop
cell
grown
coverslip
left
untreat
pretreat
correspond
inhibitor
incub
phev
plu
phev
plu
phev
plu
phev
alon
ice
min
shift
incub
min
ctb
dx
assay
nonintern
phev
remov
wash
cell
pb
three
time
ad
ml
roomtemperatur
trypsin
min
later
remov
trypsin
wash
cell
cold
complet
medium
twice
fix
cold
paraformaldehyd
pb
analyz
fix
cell
ifa
indic
antibodi
transferrin
assay
remov
substratecontain
medium
wash
cell
pb
three
time
incub
min
cold
strip
buffer
mm
nacl
mm
hepe
mm
kcl
mm
mm
ph
wash
cell
cold
pb
proceed
ifa
domain
first
clone
plasmid
encod
fusion
protein
escherichia
coli
express
induc
mm
iptg
affin
purifi
use
glutathion
sepharos
bead
amersham
pharmacia
biotech
quantifi
sdspage
cell
transfect
protein
h
follow
treatment
phev
collect
lyse
min
lysi
buffer
mm
hepe
ph
mm
nacl
mm
mm
edta
mm
dithiothreitol
dtt
glycerol
proteas
inhibitor
measur
gtpase
activ
respons
phev
infect
viru
preabsorb
cell
h
cell
collect
lyse
guanosin
gamma
thiophosph
ad
partial
lysat
activ
small
g
protein
posit
control
clarifi
centrifug
g
min
lysat
incub
purifi
protein
overnight
rotat
mixer
resin
subsequ
rins
lysi
buffer
resuspend
sd
load
buffer
western
blot
subsequ
perform
data
present
mean
sd
least
three
independ
experi
indic
statist
analys
calcul
conduct
use
twotail
student
test
oneway
analysi
varianc
anova
graphpad
prism
version
softwar
graphpad
softwar
inc
la
jolla
ca
p
valu
defin
threshold
statist
signific
singl
asterisk
result
consid
signific
p
valu
doubl
asterisk
